Publications by the researcher in collaboration with Irene Tadeo (15)

2018

  1. 1p36 deletion results in a decrease in glycosaminoglycans which is associated with aggressiveness in neuroblastic tumors

    Histology and Histopathology, Vol. 33, Núm. 5, pp. 487-495

  2. Lymph microvascularization as a prognostic indicator in neuroblastoma

    Oncotarget, Vol. 9, Núm. 40, pp. 26157-26170

2017

  1. A stiff extracellular matrix is associated with malignancy in peripheral neuroblastic tumors

    Pediatric Blood and Cancer, Vol. 64, Núm. 9

2016

  1. Comparative genetic study of intratumoral heterogenous MYCN amplified neuroblastoma versus aggressive genetic profile neuroblastic tumors

    Oncogene, Vol. 35, Núm. 11, pp. 1423-1432

  2. Extracellular matrix composition defines an ultra-high-risk group of neuroblastoma within the high-risk patient cohort

    British Journal of Cancer, Vol. 115, Núm. 4, pp. 480-489

  3. Neuroblastoma patient-derived orthotopic xenografts reflect the microenvironmental hallmarks of aggressive patient tumours

    Cancer Letters, Vol. 375, Núm. 2, pp. 384-389

  4. Vascular patterns provide therapeutic targets in aggressive neuroblastic tumors

    Oncotarget, Vol. 7, Núm. 15, pp. 19935-19947

2015

  1. Neuroblastoma patient-derived orthotopic xenografts retain metastatic patterns and geno- and phenotypes of patient tumours

    International Journal of Cancer, Vol. 136, Núm. 5, pp. E252-E261

2014

  1. Neuroblastoma after Childhood: Prognostic Relevance of Segmental Chromosome Aberrations, ATRX Protein Status, and Immune Cell Infiltration

    Neoplasia, Vol. 16, Núm. 6, pp. 471-480

  2. Quantitative modeling of clinical, cellular, and extracellular matrix variables suggest prognostic indicators in cancer: A model in neuroblastoma

    Pediatric Research, Vol. 75, Núm. 2, pp. 302-314

2013

  1. Genetic Instability and Intratumoral Heterogeneity in Neuroblastoma with MYCN Amplification Plus 11q Deletion

    PLoS ONE, Vol. 8, Núm. 1

  2. NeuPAT: An intranet database supporting translational research in neuroblastic tumors

    Computers in Biology and Medicine, Vol. 43, Núm. 3, pp. 219-228

2011

  1. Anaplastic lymphoma kinase expression in neuroblastomas and its relationship with genetic, prognostic, and predictive factors

    Human Pathology

  2. Comparative study of MLPA-FISH to determine DNA copy number alterations in neuroblastic tumors

    Histology and Histopathology, Vol. 26, Núm. 3, pp. 343-350

2010

  1. Gain of MYCN region in a wilms tumor-derived xenotransplanted cell line

    Diagnostic Molecular Pathology, Vol. 19, Núm. 1, pp. 33-39